Ruijin Hospital
Clinical trials sponsored by Ruijin Hospital, explained in plain language.
-
New hope for rare clotting disorder: drug targets antibody levels
Disease control CompletedThis study tested a drug called telitacicept in 20 adults with antiphospholipid syndrome (APS), a condition where the immune system mistakenly attacks healthy cells, raising the risk of blood clots. The goal was to see if the drug could lower high-risk antibody levels over 48 wee…
Phase: PHASE2 • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated Apr 26, 2026 20:03 UTC
-
Rituximab doses tested for blistering skin disease
Disease control CompletedThis study looked at how well different doses of rituximab work for people with pemphigus, a serious skin condition that causes blisters. Researchers tracked 275 patients to see if the drug helped control the disease and prevent relapses. The goal was to find the best dose to man…
Sponsor: Ruijin Hospital • Aim: Disease control
Last updated Apr 26, 2026 20:00 UTC